Everion goes Down Under

Biovotion offers a user-centric, analytics driven ecosystem powered by medical wearable technology. Everion, our first offspring has now received medical device class II registration in Australia. »

AFib study with Everion

We are excited to see Everion being used in a rapidly increasing number of clinical studies and RWE type of applications. Atrial fibrillation (AFib) affects an »

A number to remember!

If you are interested in medical wearables, digital health, integrated solutions and had to choose one number to memorise before the year end - here is »

Final closing Series A

ZURICH, SWITZERLAND – July 10, 2017 – Biovotion Ltd, the award-winning digital health company, is announcing the final closing of its oversubscribed CHF13M Series A financing round. Following »

Winner Deal of the Year 2016

Acquisition International: "Biovotion’s innovative solutions connect patients and providers throughout the continuum of care. We profiled the firm and explore the series A financing which »

Medica, we are coming!

We are soon to exhibit at this year’s Medica in Dusseldorf, Germany. Medica is the world’s biggest medical device industry gathering with 130'000 visitors »

Askmen from WTS 2016

Another piece of outstanding wearable tech at the show was this thing: Biovotion. This gadget also measures your vital signs but it isn't an item of »

No wearable, no policy?

Insurers grapple with wearable big data ‘revolution’ Big data is getting so large that executives from reinsurance giant Swiss Re believe it could be impossible to »